Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
about
Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Regulation of cellular iron metabolismRNA-Binding Proteins in Trichomonas vaginalis: Atypical Multifunctional ProteinsIron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null miceAbnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairmentsGenetic polymorphisms in the 9p21 region associated with risk of multiple cancersHepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblastsEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.The physiological functions of iron regulatory proteins in iron homeostasis - an update.Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration.Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide.Ferritin overexpression in Drosophila glia leads to iron deposition in the optic lobes and late-onset behavioral defects.Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse.Identification of Iron Homeostasis Genes Dysregulation Potentially Involved in Retinopathy of Prematurity Pathogenicity by Microarray AnalysisDeletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2α.Mammalian iron metabolism and its control by iron regulatory proteinsTargeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.Iron metabolism in the eye: a review.Mitochondrial iron metabolism and its role in neurodegeneration.The IRP/IRE system in vivo: insights from mouse models.Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.Drug target identification at the crossroad of neuronal apoptosis and survival.Modulating inflammation and neuroprotection in multiple sclerosis.MicroRNA-related genetic variants in iron regulatory genes, dietary iron intake, microRNAs and lung cancer risk.Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.Biophysical and genetic analysis of iron partitioning and ferritin function in Drosophila melanogaster.Effect of iron on cholesterol 7α-hydroxylase expression in alcohol-induced hepatic steatosis in mice.Translational repression of HIF2α expression in mice with Chuvash polycythemia reverses polycythemia.Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains
P2860
Q24595411-DAF8B862-0B95-4267-86CB-D23DCA9FDE5AQ24610063-8D0BDAF0-31A2-4EF2-92E0-55EDC29E6BB8Q26771978-BEC7B8EB-8BD4-4C01-80D4-13122408902AQ27318323-AB85FD2C-5333-4A4D-9E09-6AC0D8CE21ACQ27330107-5BBBEDFB-63E4-4FCE-A9A9-DADFCA6E408EQ28383262-4A19A84C-E98E-41C8-A86C-BDFF5A22AD0BQ28585215-37EFC80B-391E-4B1E-98FE-E214C24CFAC4Q33608219-9A050E35-591A-4899-A29E-5211D7EBD430Q33730408-9DAE6B57-7D82-4574-A450-27E3D125921EQ33752116-C12703B2-EEAD-40E5-8B39-A7C74F1AADA4Q34181256-B535BC4C-5FC6-4711-B1E1-54B4B5B95F6AQ34198997-6686267A-3C92-4F3F-975F-7C320356E97AQ35067691-3C4104F9-58B6-43BF-A1FE-572319105CDBQ35095084-BC7AE841-EBEE-4E81-B374-F8F70F0C079BQ36053170-1B836D95-66A6-4ABB-B4DA-5085AB222237Q36227424-41930FCD-8BD3-484F-9435-78D1BB0051A0Q36236211-81FA2D25-3095-4032-AEC2-F1090C965CA1Q36602744-9F6B1539-F188-41E2-9133-FAD4BE165F74Q36910294-184CDC8E-60CA-49EF-9D9F-C178F80315DDQ37030920-477E677B-A5A7-445F-BA12-5D0D55DA092BQ37103535-1A2739E1-2D3C-4A87-B9D6-93BE8797EF0BQ37750239-8A3434D6-2169-4945-851B-C9E7FC1F44ECQ38239649-07F564A0-6E01-47EA-A1B3-869985F0CDFFQ38627193-4F2E8F15-01CD-47E0-91E9-FB4A387653A2Q39076381-112D7654-891D-4D32-9AD5-A8E3178269F6Q39350409-DA5C1873-A467-4D17-B353-7E21D370D2B9Q40223099-26CAA55B-B644-4DE3-A1F2-0A192C522AA2Q46412279-B6FBF7D4-6CD8-4A49-8C80-8571AE7512B8Q50903918-B90D2E37-0AA5-4E1B-98CD-4532122B062CQ50985405-29DE99B9-9D01-4284-9D0E-E1DBE6F05A74Q52685425-80E46433-74D8-4241-B291-C3CE019B8510Q55112828-03207D79-BA85-401C-AD7B-D125A8E20F85Q57091761-028C638A-D031-4ED2-B86D-9C8F8E099D5B
P2860
Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@ast
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@en
type
label
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@ast
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@en
prefLabel
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@ast
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@en
P2093
P2860
P356
P1476
Tempol-mediated activation of ...... disease in IRP2 knockout mice.
@en
P2093
Anamika Singh
Deliang Zhang
Hayden Ollivierre-Wilson
James B Mitchell
Manik C Ghosh
Murali C Krishna
Tracey A Rouault
Wing-Hang Tong
P2860
P304
12028-12033
P356
10.1073/PNAS.0805361105
P407
P577
2008-08-06T00:00:00Z